Rationale and Design of a Large-Scale Trial Using Atrial Natriuretic Peptide (ANP) as an Adjunct to Percutaneous Coronary Intervention for ST-Segment Elevation …
M Asakura, K Jiyoong, T Minamino, Y Shintani… - Circulation …, 2004 - jstage.jst.go.jp
Background The benefits of percutaneous coronary intervention (PCI) in acute myocardial
infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide …
infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide …
Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction
S Kasama, M Furuya, T Toyama… - European Heart …, 2008 - academic.oup.com
Atrial natriuretic peptide (ANP) is a member of the natriuretic peptide family that exerts
various biological effects via acting on the receptor-guanylyl cyclase system, increasing the …
various biological effects via acting on the receptor-guanylyl cyclase system, increasing the …
Atrial natriuretic peptide therapy and in-hospital mortality in acute myocardial infarction patients undergoing percutaneous coronary intervention
Background Atrial natriuretic peptide (ANP) therapy has been reported to have beneficial
effects in patients with acute myocardial infarction (AMI); however, its impact on in-hospital …
effects in patients with acute myocardial infarction (AMI); however, its impact on in-hospital …
Natriuretic Peptides as an Adjunctive Treatment for Acute Myocardial Infarction Insights from the Meta-analysis of 1,389 Patients from 20 Trials
T Lyu, Y Zhao, T Zhang, W Zhou, F Yang… - International heart …, 2014 - jstage.jst.go.jp
Animal studies have reported a cardioprotective effect for atrial natriuretic peptide (ANP) or
brain natriuretic peptide (BNP) administration in the setting of acute myocardial infarction …
brain natriuretic peptide (BNP) administration in the setting of acute myocardial infarction …
Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for …
H Kuga, K Ogawa, A Oida, I Taguchi… - Circulation …, 2003 - jstage.jst.go.jp
To evaluate the effects of synthetic human atrial natriuretic peptide (hANP) on myocardial
reperfusion injury and left ventricular remodeling, 19 patients within 12h of a first attack of …
reperfusion injury and left ventricular remodeling, 19 patients within 12h of a first attack of …
Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials
M Kitakaze, M Asakura, J Kim, Y Shintani, H Asanuma… - The Lancet, 2007 - thelancet.com
Background Patients who have acute myocardial infarction remain at major risk of
cardiovascular events. We aimed to assess the effects of either human atrial natriuretic …
cardiovascular events. We aimed to assess the effects of either human atrial natriuretic …
Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction
M Hayashi, T Tsutamoto, A Wada, K Maeda… - Journal of the American …, 2001 - jacc.org
OBJECTIVES The study evaluates the effect of atrial natriuretic peptide (ANP) compared
with nitroglycerin (GTN) on left ventricular (LV) remodeling after first anterior acute …
with nitroglycerin (GTN) on left ventricular (LV) remodeling after first anterior acute …
Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts
XM Yang, S Philipp, JM Downey, MV Cohen - Basic research in cardiology, 2006 - Springer
We investigated whether atrial natriuretic peptide (ANP) given just prior to reperfusion
reduces infarction in rabbit hearts and whether protection is related to activation of protein …
reduces infarction in rabbit hearts and whether protection is related to activation of protein …
Atrial natriuretic peptide increases inflammation, infarct size, and mortality after experimental coronary occlusion
AK Houng, RA McNamee, A Kerner… - American Journal …, 2009 - journals.physiology.org
Acute coronary artery occlusion triggers the release of atrial natriuretic peptide (ANP) from
the heart. ANP affects vasodilation, natriuresis, and inflammation, but the integrated …
the heart. ANP affects vasodilation, natriuresis, and inflammation, but the integrated …
Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotection through a nitric oxide-dependent mechanism
H Okawa, H Horimoto, S Mieno, Y Nomura… - Journal of …, 2002 - europepmc.org
Objectives Alpha-human atrial natriuretic peptide (alpha-hANP) has been used to treat
patients with heart failure due to its natriuretic and vasodilatory activities. Recent reports …
patients with heart failure due to its natriuretic and vasodilatory activities. Recent reports …